Izotropic Corporation announces that effective May 31, 2023, Dr. John McGraw has resigned has stepped down from the Company Board of Directors. Dr. McGraw will remain an Advisor to the Company and consult on future projects. The Company thanks Dr. McGraw for his service and management contributions over the past three years.

Effective June 1, 2023, Izotropic Founder, Chairman, and Former CEO Mr. Robert Thast will assume the role of Interim CEO and will work closely with the Companys Directors regarding business decisions and operational matters until a new CEO is in place.